Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Strategy Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Strategy Inc. trades at $140.28 (market cap $60.65B). The key difference: Strategy Inc. is far larger — about 7.2× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Strategy Inc. for 113 Days on average.
| HNGE | MSTR | |
|---|---|---|
Market Cap | $8.47B | $60.65B |
Volume | 1,624,526 | 20,701,924 |
Sector | Health | Technology |
52-Week High | $105.14 | $301.91 |
52-Week Low | $31.17 | $82.31 |
Typical Hold Time | 0 Days | 113 Days |
Enterprise Value | $8.09B | $79.42B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
MSTR stock trades at $152.18, down 0.33% on the day, with a neutral technical signal and mixed earnings history. The company reported a net loss of $3.85 billion in 2025 despite $477.23 million in revenue, reflecting a negative net income margin of -6,102.96%. Analyst consensus remains bullish with a $253.36 price target, but cash flow from operations is negative, and the stock faces volatility linked to its Bitcoin holdings.
The outlook hinges on Bitcoin price trends and operational execution, with significant upside potential per analyst targets but high risk from sustained losses and debt. Investors must weigh the bullish sentiment against fundamental weaknesses and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
